Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial-Reference-Cited by-同舟云学术

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

Published:2008-08 Issue:9636 Volume:372 Page:383-391
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ruperto Nicolino,Lovell Daniel J,Quartier Pierre,Paz Eliana,Rubio-Pérez Nadina,Silva Clovis A,Abud-Mendoza Carlos,Burgos-Vargas Ruben,Gerloni Valeria,Melo-Gomes Jose A,Saad-Magalhães Claudia,Sztajnbok Flavio,Goldenstein-Schainberg Claudia,Scheinberg Morton,Penades Immaculada Calvo,Fischbach Michael,Orozco Javier,Hashkes Philip J,Hom Christine,Jung Lawrence,Lepore Loredana,Oliveira Sheila,Wallace Carol A,Sigal Leonard H,Block Alan J,Covucci Allison,Martini Alberto,Giannini Edward H

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study;Oliveira;Arthritis Rheum,2007

2. Juvenile idiopathic arthritis;Ravelli;Lancet,2007

3. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status;Ruperto;J Rheumatol,1997

4. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.—U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group;Giannini;N Engl J Med,1992

5. Methotrexate in juvenile idiopathic arthritis: answers and questions;Ravelli;J Rheumatol,2000

Cited by 453 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of treatment options for juvenile idiopathic arthritis;World Journal of Orthopedics;2024-09-18

2. How can trial designs better serve the needs of children and young people with juvenile idiopathic arthritis?;The Lancet Rheumatology;2024-09

3. S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis;Arthritis Research & Therapy;2024-06-25

4. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study;Annals of the Rheumatic Diseases;2024-06-07

5. Artritis idiopática juvenil;EMC - Pediatría;2024-06